The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Chemoimmunotherapy with or without locoregional therapy for biliary tract cancer: A propensity score–matched study.
 
Soravis Osataphan
No Relationships to Disclose
 
Rodrigo Paredes
No Relationships to Disclose
 
Manasawee Tanariyakul
No Relationships to Disclose
 
Riya Patel
No Relationships to Disclose
 
Hamzah Abu-Sbeih
No Relationships to Disclose
 
Ben Ponvilawan
No Relationships to Disclose
 
Ibrahim Omore
No Relationships to Disclose
 
Mrinalini Ramesh
No Relationships to Disclose
 
Seohyuk Lee
No Relationships to Disclose
 
Juan Juarez
No Relationships to Disclose
 
Sakditad Saowapa
No Relationships to Disclose
 
Edward Nguyen
No Relationships to Disclose
 
Chalothorn Wannaphut
No Relationships to Disclose
 
Marc Roth
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Roche; Takeda
 
Naomi Fei
No Relationships to Disclose
 
Arjun Mittra
Stock and Other Ownership Interests - Lilly
Research Funding - Tempus (Inst); THERIVA BIOLOGICS, SL. (Inst)
 
Jared Acoba
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - GlaxoSmithKline
 
Kannan Thanikachalam
Stock and Other Ownership Interests - Agenus; Pfizer
 
Deirdre Cohen
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Fosun Pharma; Summit Therapeutics
Speakers' Bureau - Guardant Health
Research Funding - Merck (Inst); Viome (Inst)
 
Mary Linton Peters
Stock and Other Ownership Interests - Abbott Laboratories; Amgen; Johnson & Johnson; Lilly; Medtronic; Procter & Gamble
Research Funding - AstraZeneca (Inst); Merck (Inst)